<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-34746" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Drug Labeling</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lopez</surname>
            <given-names>Michael J.</given-names>
          </name>
          <aff>Augusta Un., Medical College of Georgia</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Patel</surname>
            <given-names>Preeti</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Lopez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Preeti Patel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>9</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-34746.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">On January 24, 2006, The Food and Drug Administration (FDA), an entity of the United States Department of Health and Human Services, published a final rule on the content and format of labeling for human prescription drugs and biologics.<xref ref-type="bibr" rid="article-34746.r1">[1]</xref><xref ref-type="bibr" rid="article-34746.r2">[2]</xref><xref ref-type="bibr" rid="article-34746.r3">[3]</xref>&#x000a0;These regulations are within Title 21 of the Code of Laws of the United States of America. The term &#x0201c;drug labeling&#x0201d; in this article generally refers to any information provided with prescription drugs under the regulation of the FDA in the United States. The exact definitions of &#x0201c;drug&#x0201d; and &#x0201c;labeling&#x0201d; have been included in the U.S. Code of Laws. Under this law, the definition of a drug is: &#x0201c;(A) articles recognized in the official United States Pharmacopoeia, official Homoeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them; and (B) articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals; and (C) articles (other than food) intended to affect the structure or any function of the body of man or other animals; and (D) articles intended for use as a component of any articles specified in clause (A), (B), or (C)...&#x0201d; And label and labeling are defined as the following: &#x0201c;(a) Labeling includes all written, printed, or graphic matter accompanying an article at any time while such an article is in interstate commerce or held for sale after shipment or delivery in interstate commerce. (b) A label means any display of written, printed, or graphic matter on the immediate container of any article, or any such matter affixed to any consumer commodity or affixed to or appearing upon a package containing any consumer commodity.&#x0201d;<xref ref-type="bibr" rid="article-34746.r3">[3]</xref><xref ref-type="bibr" rid="article-34746.r4">[4]</xref><xref ref-type="bibr" rid="article-34746.r5">[5]</xref><xref ref-type="bibr" rid="article-34746.r6">[6]</xref></p>
        <p>The FDA&#x02019;s primary purpose of drug labeling is to ensure patient safety by giving healthcare professionals a summary of the safety and efficacy of a drug. The labeling is not aimed at a patient population because prescription drug administration is always under the supervision of a healthcare practitioner who is licensed to prescribe the medication.<xref ref-type="bibr" rid="article-34746.r7">[7]</xref><xref ref-type="bibr" rid="article-34746.r8">[8]</xref><xref ref-type="bibr" rid="article-34746.r9">[9]</xref><xref ref-type="bibr" rid="article-34746.r10">[10]</xref></p>
        <p>The following list is an outline of the requirements for a drug label:</p>
        <list list-type="bullet">
          <list-item>
            <p>Highlights (a concise summary of label information)</p>
          </list-item>
          <list-item>
            <p>Full prescribing information</p>
          </list-item>
          <list-item>
            <p>Limitations statement&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Product names&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Date of initial U.S. approval&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Box warnings&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Recent major changes&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Indications and&#x000a0;usage&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Dosage and administration&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Dosage forms and strengths&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Contraindications&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Warnings and precautions&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Adverse reactions (listing of most common adverse reactions)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Drug interactions&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Use in specific populations&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Patient counseling information statement</p>
          </list-item>
        </list>
        <p>Additional information on the drug label is as follows.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Overdose</p>
          </list-item>
          <list-item>
            <p>Clinical pharmacology</p>
          </list-item>
          <list-item>
            <p>Nonclinical toxicology (carcinogenesis, mutagenesis, and fertility impairment)</p>
          </list-item>
          <list-item>
            <p>Clinical studies</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-34746.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Over 50% of medication use errors in terms of dosing, intervals, route of administration, etc, are associated with poor prescription drug labeling.<xref ref-type="bibr" rid="article-34746.r11">[11]</xref>&#x000a0;Although the FDA&#x02019;s main purpose in drug labeling is to aid the healthcare provider, the patient&#x02019;s misunderstanding of labeling is a major cause of medication-related morbidity, mortality, and cost. The most common reasons for medication use errors include name confusion and inability to read or understand prescription drug labels. Research has found that medication errors would be reduced if patient-centered labeling were implemented with standardization of labeling text, scheduling, indication, language, typography, and other display standards. These evidence-based recommendations generally focus on standardizing and simplifying medication labeling for patients to better self-manage their medication use.<xref ref-type="bibr" rid="article-34746.r11">[11]</xref><xref ref-type="bibr" rid="article-34746.r12">[12]</xref></p>
      </sec>
      <sec id="article-34746.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Medication error due to misunderstanding prescription drug labeling is the most common iatrogenic error leading to injury, hospitalization, and adverse medication reactions.<xref ref-type="bibr" rid="article-34746.r13">[13]</xref>&#x000a0;This is especially problematic in patients who have low health literacy or receive prescriptions for multiple medications.<xref ref-type="bibr" rid="article-34746.r14">[14]</xref>&#x000a0;In the United States, The Food and Drug Administration (FDA) is responsible for regulating and enforcing drug labeling to protect and ensure the safety and efficacy of prescription drugs. However, the FDA&#x02019;s labeling requirements are not meant to be patient-centered. The United States Pharmacopeia (USP) has made recommendations based on the Institute of Health&#x02019;s report on medical errors. The USP recommends patient-centered prescription labels, simplifying language, using explicit text, including the reason for prescription, improved readability, labeling in a patient&#x02019;s preferred language, supplemental information, and standardized patient directions.<xref ref-type="bibr" rid="article-34746.r15">[15]</xref>&#x000a0;The drug labeling information for biosimilars compares the reference product more comprehensively than traditional generic drugs. This ensures that prescribers have clear access to the source of information, enabling them to understand the therapeutic profile associated with each biosimilar agent.<xref ref-type="bibr" rid="article-34746.r16">[16]</xref></p>
      </sec>
      <sec id="article-34746.s4" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>The healthcare team, eg, physicians, pharmacists, and nurses, must work together to ensure that patients use medications safely. The healthcare team needs to enthusiastically educate patients on correctly storing and administering their medications, especially for pediatric and geriatric patients. The findings of a recent study reveal that a significant number of households in the United States fail to comply with proper medication storage guidelines, thereby increasing the risk of compromising the sterility and stability of the drugs. The findings underscore the importance of pharmacist-led education initiatives to empower patients with the knowledge needed for proper medication storage, ultimately minimizing the risk of accidental ingestion and ensuring optimal therapeutic outcomes.<xref ref-type="bibr" rid="article-34746.r17">[17]</xref>&#x000a0;Physicians&#x000a0;should discuss the medication with the patient, and the medication administration and storage instructions should be reinforced by the nurse and pharmacist, for example, in an ambulatory care setting.</p>
      </sec>
      <sec id="article-34746.s5">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=34746&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=34746">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/34746/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=34746">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-34746.s6">
        <title>References</title>
        <ref id="article-34746.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kremzner</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Introduction to the new prescription drug labeling by the Food and Drug Administration.</article-title>
            <source>Am J Health Syst Pharm</source>
            <year>2007</year>
            <month>Dec</month>
            <day>01</day>
            <volume>64</volume>
            <issue>23</issue>
            <fpage>2488</fpage>
            <page-range>2488-94</page-range>
            <pub-id pub-id-type="pmid">18029957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34746.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <collab>Food and Drug Administration, HHS</collab>
            <article-title>Requirements on content and format of labeling for human prescription drug and biological products. Final rule.</article-title>
            <source>Fed Regist</source>
            <year>2006</year>
            <month>Jan</month>
            <day>24</day>
            <volume>71</volume>
            <issue>15</issue>
            <fpage>3921</fpage>
            <page-range>3921-97</page-range>
            <pub-id pub-id-type="pmid">16479698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34746.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <collab>Food and Drug Administration, HHS</collab>
            <article-title>Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.</article-title>
            <source>Fed Regist</source>
            <year>2003</year>
            <month>Dec</month>
            <day>11</day>
            <volume>68</volume>
            <issue>238</issue>
            <fpage>69009</fpage>
            <page-range>69009-20</page-range>
            <pub-id pub-id-type="pmid">14672084</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34746.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gassman</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Joffe</surname>
                <given-names>HV</given-names>
              </name>
            </person-group>
            <article-title>FDA Regulation of Prescription Drugs.</article-title>
            <source>N Engl J Med</source>
            <year>2017</year>
            <month>Feb</month>
            <day>16</day>
            <volume>376</volume>
            <issue>7</issue>
            <fpage>674</fpage>
            <page-range>674-682</page-range>
            <pub-id pub-id-type="pmid">28199811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34746.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aikin</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>O'Donoghue</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Swasy</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>Randomized trial of risk information formats in direct-to-consumer prescription drug advertisements.</article-title>
            <source>Med Decis Making</source>
            <year>2011</year>
            <season>Nov-Dec</season>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>E23</fpage>
            <page-range>E23-33</page-range>
            <pub-id pub-id-type="pmid">21690303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34746.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gruber</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>The US FDA pregnancy lactation and labeling rule - Implications for maternal immunization.</article-title>
            <source>Vaccine</source>
            <year>2015</year>
            <month>Nov</month>
            <day>25</day>
            <volume>33</volume>
            <issue>47</issue>
            <fpage>6499</fpage>
            <page-range>6499-500</page-range>
            <pub-id pub-id-type="pmid">26256527</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34746.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <collab>Food and Drug Administration, HHS</collab>
            <article-title>Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule.</article-title>
            <source>Fed Regist</source>
            <year>2014</year>
            <month>Dec</month>
            <day>04</day>
            <volume>79</volume>
            <issue>233</issue>
            <fpage>72063</fpage>
            <page-range>72063-103</page-range>
            <pub-id pub-id-type="pmid">25509060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34746.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramoz</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Patel-Shori</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Recent changes in pregnancy and lactation labeling: retirement of risk categories.</article-title>
            <source>Pharmacotherapy</source>
            <year>2014</year>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>389</fpage>
            <page-range>389-95</page-range>
            <pub-id pub-id-type="pmid">24390829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34746.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <collab>Food and Drug Administration, HHS</collab>
            <article-title>Amendment of regulations regarding certain label statements on prescription drugs. Final rule.</article-title>
            <source>Fed Regist</source>
            <year>2002</year>
            <month>Feb</month>
            <day>01</day>
            <volume>67</volume>
            <issue>22</issue>
            <fpage>4904</fpage>
            <page-range>4904-7</page-range>
            <pub-id pub-id-type="pmid">11829025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34746.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <collab>Food and Drug Administration, HHS</collab>
            <article-title>Use of Symbols in Labeling. Final rule.</article-title>
            <source>Fed Regist</source>
            <year>2016</year>
            <month>Jun</month>
            <day>15</day>
            <volume>81</volume>
            <issue>115</issue>
            <fpage>38911</fpage>
            <page-range>38911-31</page-range>
            <pub-id pub-id-type="pmid">27311137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34746.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeetu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Girish</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Prescription drug labeling medication errors: a big deal for pharmacists.</article-title>
            <source>J Young Pharm</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>107</fpage>
            <page-range>107-11</page-range>
            <pub-id pub-id-type="pmid">21331202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34746.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yin</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Sanders</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Mendelsohn</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dreyer</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Jimenez</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Jacobson</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>MCJ</given-names>
              </name>
              <name>
                <surname>Hedlund</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Meyers</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>McFadden</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Pictograms, Units and Dosing Tools, and Parent Medication Errors: A Randomized Study.</article-title>
            <source>Pediatrics</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>140</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">28759396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34746.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolf</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Knox</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Bergeron</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abbet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shrank</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>A Patient-Centered Prescription Drug Label to Promote Appropriate Medication Use and Adherence.</article-title>
            <source>J Gen Intern Med</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>12</issue>
            <fpage>1482</fpage>
            <page-range>1482-1489</page-range>
            <pub-id pub-id-type="pmid">27542666</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34746.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ryan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Santesso</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lowe</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grimshaw</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Prictor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kaufman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cowie</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2014</year>
            <month>Apr</month>
            <day>29</day>
            <volume>2014</volume>
            <issue>4</issue>
            <fpage>CD007768</fpage>
            <pub-id pub-id-type="pmid">24777444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34746.r15">
          <label>15</label>
          <element-citation publication-type="book">
            <collab>Institute of Medicine (US) Roundtable on Health Literacy</collab>
            <source>The Safe Use Initiative and Health Literacy: Workshop Summary</source>
            <publisher-name>National Academies Press (US)</publisher-name>
            <publisher-loc>Washington (DC)</publisher-loc>
            <year>2010</year>
            <pub-id pub-id-type="pmid">24983047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34746.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harvey</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Science of Biosimilars.</article-title>
            <source>J Oncol Pract</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>13</volume>
            <issue>9_suppl</issue>
            <fpage>17s</fpage>
            <page-range>17s-23s</page-range>
            <pub-id pub-id-type="pmid">28898589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-34746.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Funk</surname>
                <given-names>OG</given-names>
              </name>
              <name>
                <surname>Yung</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Arrighi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Medication Storage Appropriateness in US Households.</article-title>
            <source>Innov Pharm</source>
            <year>2021</year>
            <volume>12</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">34345509</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
